Literature DB >> 21351218

Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Laurie Keefer1, Bethany Doerfler, Caroline Artz.   

Abstract

BACKGROUND: Psychotherapy for Crohn's disease (CD) has focused on patients with psychological distress. Another approach to optimize management of CD is to target patients who do not exhibit psychological distress but engage in behaviors that undermine treatment efficacy / increase risk for flare. We sought to determine the feasibility/acceptability and estimate the effects of a program framed around Project Management (PM) principles on CD outcomes.
METHODS: Twenty-eight adults with quiescent CD without a history of psychiatric disorder were randomized to PM (n = 16) or treatment as usual (TAU; n = 12). Baseline and follow-up measures were Inflammatory Bowel Disease Questionnaire (IBDQ), Medication Adherence Scale (MAS), Perceived Stress Questionnaire (PSQ), and IBD Self-Efficacy Scale (IBD-SES).
RESULTS: There were significant group × time effects favoring PM on IBDQ-Total Score (F(1) = 15.2, P = 0.001), IBDQ-Bowel (F(1) = 6.5, P = 0.02), and IBDQ-Systemic (F(1) = 9.3, P = 0.007) but not IBDQ-Emotional (F(1) = 1.9, P = ns) or IBDQ-Social (F(1) = 2.4, P = ns). There was a significant interaction effect favoring PM with respect to PSQ (F(1) = 8.4, P = 0.01) and IBD-SES (F(1) = 12.2, P = 0.003). There was no immediate change in MAS (F(1) = 4.3, P = ns). Moderate effect sizes (d > 0.30) were observed for IBDQ total score (d = 0.45), IBDQ bowel health (d = 0.45), and systemic health (d = 0.37). Effect sizes for PSQ (d = 0.13) and IBDSES (d = 0.17) were smaller.
CONCLUSIONS: Behavioral programs that appeal to patients who may not seek psychotherapy for negative health behaviors may improve quality of life and potentially disease course and outcomes.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21351218      PMCID: PMC3111841          DOI: 10.1002/ibd.21679

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  79 in total

Review 1.  A critical review of self-management and educational interventions in inflammatory bowel disease.

Authors:  Cate Barlow; Debbie Cooke; Kathleen Mulligan; Eric Beck; Stanton Newman
Journal:  Gastroenterol Nurs       Date:  2010 Jan-Feb       Impact factor: 0.978

2.  Information needs and preferences in IBD (IBD self-management: the AGA guide to Crohn's disease and ulcerative colitis).

Authors:  Sunanda Kane
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

3.  Adherence rates with infliximab therapy in Crohn's disease.

Authors:  S Kane; L Dixon
Journal:  Aliment Pharmacol Ther       Date:  2006-10-01       Impact factor: 8.171

4.  Social cognitive theory: an agentic perspective.

Authors:  A Bandura
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

5.  Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients.

Authors:  Jason M Swoger; Edward V Loftus; William J Tremaine; William A Faubion; Darrell S Pardi; Sunanda V Kane; Karen A Hanson; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

6.  Evaluation of a psychological treatment for inflammatory bowel disease.

Authors:  S P Schwarz; E B Blanchard
Journal:  Behav Res Ther       Date:  1991

7.  Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Michael P Jones; Sarah Wessinger; Michael D Crowell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

8.  Community-based peer-led diabetes self-management: a randomized trial.

Authors:  Kate Lorig; Philip L Ritter; Frank J Villa; Jean Armas
Journal:  Diabetes Educ       Date:  2009-04-30       Impact factor: 2.140

9.  Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research.

Authors:  S Levenstein; C Prantera; V Varvo; M L Scribano; E Berto; C Luzi; A Andreoli
Journal:  J Psychosom Res       Date:  1993-01       Impact factor: 3.006

Review 10.  Self-care and the doctor-patient relationship.

Authors:  Stanford Shoor; Kate R Lorig
Journal:  Med Care       Date:  2002-04       Impact factor: 2.983

View more
  11 in total

Review 1.  A Systematic Review of Self-Management Interventions for Inflammatory Bowel Disease.

Authors:  Samantha Conley; Nancy Redeker
Journal:  J Nurs Scholarsh       Date:  2016-01-12       Impact factor: 3.176

Review 2.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 3.  Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Authors:  Tiffany H Taft; Sarah Ballou; Alyse Bedell; Devin Lincenberg
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

Review 4.  Distance management of inflammatory bowel disease: systematic review and meta-analysis.

Authors:  Vivian W Huang; Krista M Reich; Richard N Fedorak
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

5.  The causal representation of outpatients with Crohn's disease: is there a link between psychological distress and clinical disease activity?

Authors:  Ingrid Banovic; Daniel Gilibert; Anne Andronikof; Ahmed Jebrane; Ivan Ajdukovic; Jaques Cosnes
Journal:  Psychosoc Med       Date:  2013-12-16

6.  Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.

Authors:  Micol Artom; Wladyslawa Czuber-Dochan; Jackie Sturt; Christine Norton
Journal:  Trials       Date:  2017-05-11       Impact factor: 2.279

7.  Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.

Authors:  Sarah Ballou; Laurie Keefer
Journal:  Clin Transl Gastroenterol       Date:  2017-01-19       Impact factor: 4.488

8.  Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease.

Authors:  Che-Yung Chao; Carolyne Lemieux; Sophie Restellini; Waqqas Afif; Alain Bitton; Peter L Lakatos; Gary Wild; Talat Bessissow
Journal:  Saudi J Gastroenterol       Date:  2019 May-Jun       Impact factor: 2.485

9.  Systematic review: outcomes and adverse events from randomised trials in Crohn's disease.

Authors:  Heather Catt; Dyfrig Hughes; Jamie J Kirkham; Keith Bodger
Journal:  Aliment Pharmacol Ther       Date:  2019-03-03       Impact factor: 8.171

10.  Improving Maintenance Medication Adherence in Adult Inflammatory Bowel Disease Patients: A Pilot Study.

Authors:  Michelle L Matteson-Kome; Jessica Winn; Matthew L Bechtold; Jack D Bragg; Cynthia L Russell
Journal:  Health Psychol Res       Date:  2014-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.